CTLT stock icon

Catalent
CTLT

$55.95
0.25%
 

About: Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Employees: 17,219

0
Funds holding %
of 6,689 funds
0
Analysts bullish %
of 6 analysts
0
News positive %
of 4 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

29.76% more ownership

Funds ownership: 109.82% [Q4 2023] → 139.58% (+29.76%) [Q1 2024]

25% more call options, than puts

Call options by funds: $48.6M | Put options by funds: $38.8M

13% more funds holding in top 10

Funds holding in top 10: 8 [Q4 2023] → 9 (+1) [Q1 2024]

10% more capital invested

Capital invested by funds: $8.91B [Q4 2023] → $9.82B (+$911M) [Q1 2024]

1% more funds holding

Funds holding: 413 [Q4 2023] → 419 (+6) [Q1 2024]

7% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 88

14% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 152

Research analyst outlook

6 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$47
16%
downside
Avg. target
$61
9%
upside
High target
$64
13%
upside

6 analyst ratings

positive
0%
neutral
100%
negative
0%
Stephens & Co.
Jacob Johnson
13%upside
$63.5
Equal-Weight
Reiterated
4 Apr 2024
RBC Capital
Sean Dodge
13%upside
$63.5
Sector Perform
Reiterated
20 Feb 2024
RBC Capital
Sean Dodge
13%upside
$63.5
Sector Perform
Downgraded
6 Feb 2024
UBS
John Sourbeer
13%upside
$63.5
Neutral
Downgraded
6 Feb 2024
Stephens & Co.
Jacob Johnson
13%upside
$63.5
Equal-Weight
Downgraded
6 Feb 2024

Financial journalist opinion

Based on 4 articles about CTLT published over the past 30 days